Join to View Full Profile
20 York StNew Haven, CT 06510
Phone+1 203-688-4242
Dr. Haberli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Nicholas Haberli, MD, is a neurology resident and chief resident at Yale-New Haven Hospital, located in New Haven, CT. Having completed his medical education at UConn School of Medicine in 2021, he specializes in neurology with a subspecialty in neurooncology. Dr. Haberli has contributed to the field with publications, including a case study on Moyamoya vasculopathy and articles on multiple sclerosis in "The Neurohospitalist" and "Multiple Sclerosis and Related Disorders". His work on ocrelizumab in multiple sclerosis populations has been cited multiple times, indicating engagement with ongoing research in his field.
Education & Training
Uconn School Of MedicineClass of 2021
Certifications & Licensure
CT State Medical License 2021 - 2025
Publications & Presentations
PubMed
- A Case of Moyamoya Vasculopathy Presenting as Simultaneous Ischemic and Hemorrhagic Strokes.Wayne Zhong, Amit Mehta, Nicholas Haberli, Ahmed Elmashad, Rachel Forman
The Neurohospitalist. 2024-11-21 - 12 citationsReal-world experience of ocrelizumab initiation in a diverse multiple sclerosis populationHamza Coban, Sarah Germaine, Ian Limuel Dimaandal, Nicholas Haberli, Charanpreet Padam
Multiple Sclerosis and Related Disorders. 2021-05-19 - 5 citationsBabesia microti infection in a patient with multiple sclerosis treated with ocrelizumab.Nicholas Haberli, Hamza Coban, Charanpreet Padam, Jairo M. Montezuma-Rusca, Marina A. Creed
Multiple Sclerosis and Related Disorders. 2021-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
